Biotechnology Bulletin ›› 2021, Vol. 37 ›› Issue (10): 120-127.doi: 10.13560/j.cnki.biotech.bull.1985.2020-1497

Previous Articles     Next Articles

Transcription Variations of Key Genes in the Central Metabolism Pathways of the Sterols Transformation in Mycobacterium

XIONG Liang-bin1,2(), SUN Ji1, LIU Xian-zhou1, QU Zhan-guo1, JI Yu-qing1, XU Yi-xin1(), WANG Feng-qing2()   

  1. 1. Collaborative Scientific Research Center/School of Pharmacy,Shanghai University of Medicine and Health Sciences,Shanghai 201318
    2. School of Bioengineering,East China University of Science and Technology,Shanghai 200237
  • Received:2020-12-09 Online:2021-10-26 Published:2021-11-12
  • Contact: XU Yi-xin,WANG Feng-qing E-mail:lbxiong2010@163.com;xuyx@sumhs.edu.cn;fqwang@ecust.edu.cn

Abstract:

To investigate the regulation mechanism of central metabolism during the transformation of sterols to steroidal drug intermediates in Mycobacterium neoaurum,RNA sequencing and qRT-PCR analysis were employed to analyze the transcriptional levels of key genes in the central metabolism of steroid drug intermediate-producing strains. Meanwhile,the glucose consuming rate during the transformation process was assessed. The results showed that the transcription of pfkB and pyk in glycolytic pathway was downregulated by 1.96-fold and 1.49-fold. The transcription of zwf and gntZ in pentose phosphate pathway was downregulated by 3.57-fold and 2.43-fold. And the citA,icd2 and kdg transcription were downregulated about 2.5-fold,1.78-fold and 1.92-fold,respectively. In addition,the determination of glucose consumption rate revealed that the initial metabolic rate of the steroidal intermediate-producing strain was significantly lower than that of the wild-type strain. This indicated that the central metabolic pathway of M. neoaurum was inhibited to some extent during the conversion of sterols to value-added steroidal intermediates.

Key words: Mycobacterium neoaurum, steroidal drug intermediate, central metabolism, 9-OHAD, glucose